Spronk Elena, Sykes Gina, Falcione Sarina, Munsterman Danielle, Joy Twinkle, Kamtchum-Tatuene Joseph, Jickling Glen C
Division of Neurology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Neuroscience and Mental Health Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Front Neurol. 2021 May 14;12:661955. doi: 10.3389/fneur.2021.661955. eCollection 2021.
Hemorrhagic transformation (HT) is a common complication in patients with acute ischemic stroke. It occurs when peripheral blood extravasates across a disrupted blood brain barrier (BBB) into the brain following ischemic stroke. Preventing HT is important as it worsens stroke outcome and increases mortality. Factors associated with increased risk of HT include stroke severity, reperfusion therapy (thrombolysis and thrombectomy), hypertension, hyperglycemia, and age. Inflammation and the immune system are important contributors to BBB disruption and HT and are associated with many of the risk factors for HT. In this review, we present the relationship of inflammation and immune activation to HT in the context of reperfusion therapy, hypertension, hyperglycemia, and age. Differences in inflammatory pathways relating to HT are discussed. The role of inflammation to stratify the risk of HT and therapies targeting the immune system to reduce the risk of HT are presented.
出血性转化(HT)是急性缺血性卒中患者的常见并发症。它发生在缺血性卒中后,外周血通过受损的血脑屏障(BBB)渗入脑内。预防HT很重要,因为它会使卒中预后恶化并增加死亡率。与HT风险增加相关的因素包括卒中严重程度、再灌注治疗(溶栓和取栓)、高血压、高血糖和年龄。炎症和免疫系统是BBB破坏和HT的重要促成因素,并且与HT的许多风险因素相关。在本综述中,我们阐述了在再灌注治疗、高血压、高血糖和年龄背景下炎症和免疫激活与HT的关系。讨论了与HT相关的炎症途径的差异。介绍了炎症在分层HT风险中的作用以及针对免疫系统以降低HT风险的治疗方法。